Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep;16(9):460.
doi: 10.1038/s41582-020-0394-7.

Aspirin and ibuprofen could lower risk of LRRK2 Parkinson disease

Ian Fyfe  1
Affiliations
Comment

Aspirin and ibuprofen could lower risk of LRRK2 Parkinson disease

Ian Fyfe. Nat Rev Neurol. 2020 Sep.
No abstract available

PubMed Disclaimer

Comment on

  • Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance.
    San Luciano M, Tanner CM, Meng C, Marras C, Goldman SM, Lang AE, Tolosa E, Schüle B, Langston JW, Brice A, Corvol JC, Goldwurm S, Klein C, Brockman S, Berg D, Brockmann K, Ferreira JJ, Tazir M, Mellick GD, Sue CM, Hasegawa K, Tan EK, Bressman S, Saunders-Pullman R; Michael J. Fox Foundation LRRK2 Cohort Consortium. San Luciano M, et al. Mov Disord. 2020 Oct;35(10):1755-1764. doi: 10.1002/mds.28189. Epub 2020 Jul 14. Mov Disord. 2020. PMID: 32662532 Free PMC article.

References

Original article
    1. San Luciano, M. et al. Nonsteroidal anti-inflammatory use and LRRK2 Parkinson’s disease penetrance. Mov. Disord. https://doi.org/10.1002/mds.28189 (2020) - DOI - PubMed
Related article
    1. Tolosa, E. et al. LRRK2 in Parkinson disease: challenges of clinical trials. Nat. Rev. Neurol. 16, 97–107 (2020) - DOI